The Benefits of myPlan to Help Identify High-Risk Patients With NSCLC

Video

Jeffrey Schneider, MD, chief of hematology and medical oncology, Winthrop University Hospital, discusses the benefits of Myriad's myPlan in determining high-risk patients with non-small cell lung cancer (NSCLC).

Related Videos
Related Content